CoChat

Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations

Open access
Zucker, Deborah R., Ruthazer, Robin, Schmid, Christopher H. · 2010 · Journal of Clinical Epidemiology
Cited by 184

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Abstract/Summary Objective To compare different statistical models for combining N-of-1 trials to estimate a population treatment effect. Study Design and Setting Data from a published series of N-of-1 trials comparing amitriptyline therapy and combination treatment (amitriptyline + fluoxetine ) were analyzed to compare summary and individual participant data meta-analysis, repeated measures models, Bayesian hierarchical models, single-period, single-pair and averaged outcome crossover models. Results The best fitting model included a random intercept (response on amitriptyline) and fixed treatment effect (added fluoxetine). Results supported a common, uncorrelated within-patient covariance structure that is equal between-treatments and across patients. Assuming unequal within-patient variances, a random effects model was favored. Bayesian hierarchical models improved precision and were highly sensitive to within-patient variance priors. Conclusion Optimal models for combining N-of-1 trials need to consider goals, data sources, and relative within and between patient variances. Without sufficient patients, between-patient variation will be hard to explain with covariates. N-of-1 data with few observations per patients may not support models with heterogeneous within-patient variation. With common variances, models appear robust. Bayesian models may improve parameter estimation but are sensitive to prior assumptions about variance components. With limited resources, improving within-patient precision must be balanced by increased participants to explain population variation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jclinepi.2010.04.020

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 20

  1. Guyatt, 1986, Determining optimal therapy randomized trials in individual patients, N Engl J Med, 314, 889, 10.1056/NEJM198604033141406 · DOI · Paper page
  2. Zucker, 1997, Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment, J Clin Epidemiol, 50, 401, 10.1016/S0895-4356(96)00429-5 · DOI · Paper page
  3. March, 1994, n of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis, BMJ, 309, 1041, 10.1136/bmj.309.6961.1041 · DOI
  4. Jaeschke, 1991, Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials, J Rheumatol, 18, 447
  5. Zucker, 2006, Lessons learned combining N-of-1 trials to assess fibromyalgia therapies 1, J Rheumatol, 33, 2069
  6. Mahon, 1999, Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice, Chest, 115, 38, 10.1378/chest.115.1.38 · DOI
  7. Johannessen, 1992, Cimetidine on-demand in dyspepsia. Experience with randomized controlled single-subject trials, Scand J Gastroenterol, 27, 189, 10.3109/00365529208999947 · DOI
  8. Guyatt, 1990, The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience, Ann Intern Med, 112, 293, 10.7326/0003-4819-112-4-293 · DOI · Paper page
  9. Larson, 1993, Randomized clinical trials in single patients during a 2-year period, JAMA, 270, 2708, 10.1001/jama.1993.03510220064035 · DOI · Paper page
  10. Guyatt, 1990, N of 1 randomized trials for investigating new drugs, Control Clin Trials, 11, 88, 10.1016/0197-2456(90)90003-K · DOI
  11. Guyatt, 1988, A clinician's guide for conducting randomized trials in individual patients, CMAJ, 139, 497
  12. Avins, 2005, Use of an embedded N-of-1 trial to improve adherence and increase information from a clinical study, Contemp Clin Trials, 26, 397, 10.1016/j.cct.2005.02.004 · doi:10.1016/j.cct.2005.02.004
  13. DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 · DOI · Paper page
  14. Whitehead, 2001, Meta-analysis of ordinal outcomes using individual patient data, Stat Med, 20, 2243, 10.1002/sim.919 · DOI · Paper page
  15. Higgins, 2001, Meta-analysis of continuous outcome data from individual patients, Stat Med, 20, 2219, 10.1002/sim.918 · DOI · Paper page
  16. Ishak, 2007, Meta-analysis of longitudinal studies 1, Clin Trials, 4, 525, 10.1177/1740774507083567 · DOI · Paper page
  17. Burckhardt, 1991, The fibromyalgia impact questionnaire: development and validation, J Rheumatol, 18, 728
  18. Schwarz, 1978, Estimating the dimension of a model, Ann Stat, 6, 461, 10.1214/aos/1176344136 · DOI · Paper page
  19. Goldenberg, 1996, A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia, Arthritis Rheum, 39, 1852, 10.1002/art.1780391111 · DOI · Paper page
  20. Lau, 1995, Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care, J Clin Epidemiol, 48, 45, 10.1016/0895-4356(94)00106-Z · DOI · Paper page

Cited by

See all 184

Metadata

Authors
Zucker, D. R., Ruthazer, R., & Schmid, C. H.
Venue
Journal of Clinical Epidemiology
Publisher
Elsevier BV
Published
2010-12
Volume
63
Issue
12
Pages
1312-1323
ISSN
0895-4356 (ISSN-L)
OpenAlex
W2133197025
Cited by
184
References
5
FWCI
3.50
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (RO1 AR45416)
  • The National Institute of Arthritis and Musculoskeletal and Skin Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations. https://app.cochat.ai/papers/10.1016/j.jclinepi.2010.04.020
The paper
Zucker, D. R., Ruthazer, R., & Schmid, C. H. (2010). Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations. Journal of Clinical Epidemiology. https://doi.org/10.1016/j.jclinepi.2010.04.020

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.